Spire Wealth Management’s IVERIC bio ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-25
Closed -$984 – 2505
2023
Q2
$984 Hold
25
– – ﹤0.01% 2311
2023
Q1
$608 Buy
+25
New +$547 ﹤0.01% 2457
2022
Q3
– Sell
-800
Closed -$8K – 2704
2022
Q2
$8K Sell
800
-800
-50% -$10K ﹤0.01% 2008
2022
Q1
$27K Sell
1,600
-25
-2% -$369 ﹤0.01% 1692
2021
Q4
$27K Buy
1,625
+25
+2% +$410 ﹤0.01% 2016
2021
Q3
$26K Sell
1,600
-1,600
-50% -$17.4K ﹤0.01% 1755
2021
Q2
$20K Sell
3,200
-25
-0.8% -$161 ﹤0.01% 1877
2021
Q1
$20K Buy
+3,225
New +$19.6K ﹤0.01% 2159

Spire Wealth Management's ISEE Position: Q3 2023 in Review

Spire Wealth Management sold out of IVERIC bio (ISEE) in Q3 2023, closing a stake of 25 shares — an estimated $984 sold.

Spire Wealth Management first reported a position in ISEE in Q1 2021 and held it in 8 quarters. The position peaked at $27K in Q1 2022. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Spire Wealth Management reported no remaining IVERIC bio position as of Q3 2023 after selling out during the quarter.
  • Spire Wealth Management sold 25 IVERIC bio shares in Q3 2023, an estimated $984.
  • Spire Wealth Management first reported a position in IVERIC bio in Q1 2021 and held it in 8 quarters.
  • Spire Wealth Management's IVERIC bio position peaked at $27K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held IVERIC bio as of Q3 2023.

Based on Spire Wealth Management's 13F filing for Q3 2023, filed 8 Nov 2023.